Wed.May 22, 2024

article thumbnail

Do You Want to Learn About Professional Intimate Skin Care for Women? [Survey]

MedEsthetics

Do you want to learn about innovations in professional intimate skin care for women? Answer our 1-question survey and let us know!

article thumbnail

Skin Detox: How To Smooth And Refresh Your Complexion

Eminence Organics

Skin Detox: How To Smooth And Refresh Your Complexion Written By (old): Thea Christie Detox diets are everywhere but what about a skin detox? After over-indulging in tasty treats and lounge time, why not start fresh with a fresh face. Whether you’re dealing with dullness, uneven skin tone, blemishes, dry skin or all of the above, here are our recommendations for a full skin detoxification.

Pores 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Issue of Research Fraud, featuring Reese Richardson

The Eco Well Podcasts

This episode features a deep dive conversation into the world of research fraud, featuring research fraud researcher Reese Richardson. What is the issue, why is it happening, and how should we think about all of this when we’re thinking about the quality of scientific research and science itself. We also explored turmeric research as a case example of research fraud in action and the impacts that’s had both on society.

52
article thumbnail

Zai Lab Initiates Global Phase 2 Clinical Trial of Topical 1L-17 Blocker in Chronic Plaque Psoriasis

The Dermatology Digest

The first patient has been dosed in Zai Lab’s global Phase 2 clinical trial of ZL-1102, a topical anti-IL-17 investigational therapy for the treatment of mild to moderate chronic plaque psoriasis. ZL-1102 is a novel human VH antibody fragment (Humabody), targeting the IL-17A cytokine, formulated as a hydrogel for topical use in the treatment of chronic plaque psoriasis.

Clinic 36
Find a school
article thumbnail

IL-17 Pathway Linked to HIF-1-alpha Activation in Psoriasis

Dermatology Times

Researchers from NYU Langone recently published a study clarifying the role of HIF-1-alpha in inflammation and psoriasis, which has been unclear until now.

36
article thumbnail

Nevisense’s EIS Technology Improves Correct Biopsy Choice for Melanomas, Other Lesions

The Dermatology Digest

Nevisense improves the rate of correct biopsy choice even after dermoscopy, according to a study conducted in Germany. Nevisense uses electrical impedance spectroscopy (EIS), a noninvasive technology that sends a painless, very low voltage electrical current through a pigmented lesion to determine if it is benign or malignant. The article appears in SKIN – The journal of cutaneous medicine. “This is a very important study and results for SciBase as it quantifies the improvement in cl

More Trending

article thumbnail

Top 6 Uncommon Signs of Skin Cancer: Beyond the Ordinary Symptoms

US Dermatologt Partners

New, different, or changing lesions are what most people think about when they hear the words, ‘skin cancer,’ but these are only the beginning when it comes to skin cancer symptoms. According to Dr. Drew Reese of U.S. Dermatology Partners in Goodyear, Arizona , “If you notice any changes or irregularities in the appearance or texture of the skin, you should have it looked at by a professional.

article thumbnail

VYN201 for Vitiligo: Promising Data Showcases Potential of BET Inhibition

Dermatology Times

VYNE Therapeutics' Iain Stuart, PhD, spoke with Dermatology Times to discuss recent phase 1 and pre-clinical data for VYN201 for vitiligo.

Clinic 36
article thumbnail

Mohs Surgical Training Around the World: Need for Standardized Database

Dermatology Times

While MMS is recognized as the gold standard for skin cancer treatment, numerous challenges still hinder widespread adoption and practice.